Ritter Daniher Financial Advisory LLC / DE
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1936603
CINCINNATI, OH
Position in VRTX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$126,666
+$742 QoQ
Shares Held
255
-9.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,458
of 1,735 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ritter Daniher Financial Advisory LLC / DE holds $155,951 across 5 Biotechnology names. VRTX ranks #1 (81.2% of the industry book) .
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,666 | 255 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $125,924 | 282 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $127,847 | 282 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $110,442 | 282 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $125,546 | 282 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $136,719 | 282 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $119,601 | 297 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $151,616 | 326 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $152,802 | 326 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $136,271 | 326 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $164,383 | 404 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $156,483 | 450 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $93,608 | 266 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $83,808 | 266 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $76,815 | 266 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||